Increasing PrEP Uptake in PWID
Season 5, Ep. 4
Take our post-test to claim CME credits.
To read a companion newsletter click here.
|People who inject drugs (PWID) are at risk for HIV infection from both sexual- as well as injection-related causes. What can clinicians do to reduce the incidence of infection and improve their patients’ health? In this issue, Dr. Jessica Taylor from The Boston University School of Medicine and Boston Medical Center takes us into the clinic to explain how current evidence-based strategies can increase the uptake of HIV pre-exposure prophylaxis in this vulnerable population.|
6/4/2021 - ECMO Therapy
Arron Berry, RN, BSN, CCRN, PHRN, CFRNdiscusses ECMO therapy for COVID-19 patients. Topics: *When to consider ECMO therapy *The two types of ECMO for COVID-19 patients *Can patients bepronedwhile on ECMO? *Is there increased risk of clotting the ECMO circuit in patients with COVID-19?Post-test forCME/CE credit:https://covid19.dkbmed.com/multispecialty/6-4-21-episode/evalAccess our resource center, download webinar slides, and claim credit athttps://covid19.dkbmed.com/Presentingfaculty:Arron Berry, RN, BSN, CCRN, PHRN, CFRN, Johns Hopkins – Lifeline Critical Care Transport, Nurse Clinician III
5-26-2021 - Q&A
Dr. Paul Auwaerter answers your COVID-19 questions. Topics: *News on theB.1.617variant and vaccine effectiveness against it *Discussion of booster immunizations *Methods to encourage adolescent vaccination *Famotidine and other treatments for mild to moderate COVID-19 *Referring rural residents for infusion therapy *Defining “Long COVID” and how to prevent itPost-test for CME/CE credit:https://covid19.dkbmed.com/multispecialty/5-26-21-episode/evalAccess our resource center, download webinar slides, and claim credit athttps://covid19.dkbmed.com/multispecialtyPresentingfaculty:Paul G. Auwaerter, MD, MBA, FIDSAPast President of the Infectious Diseases Society of America (IDSA)Professor of Medicine, Johns Hopkins University School of Medicine
5/19/2021 - Patient Case Study Challenge
In thislivewebinar,Charles Vega, MD andMichaelAngarone, DO, FIDSAanalyzetwo COVID-19 patientcase studies:onepatient is experiencingmoderate symptomsandtheotherisin the hospital withsevere symptoms.Can you make the right treatment decisions?Theydiscuss:Accurately identifying patients eligible forauthorized treatmentsViral variants’impact ontreatmentsThe latesttreatmentrecommendations and clinical dataExpert FacultyCharles Vega, MDClinical Professor, Family MedicineDirector, UC Irvine Program in Medical Education for the Latino Community, Family MedicineSchool of Medicine Assistant Dean for Culture and Community EducationUC Irvine School of MedicineMichaelAngarone, DO, FIDSAAssociate ProfessorDivision of Infectious DiseasesDepartments of Medicine and Medical EducationNorthwestern University Feinberg School of Medicine